Predictors of HBeAg loss after nucleos(t)ide analogues treatment for chronic hepatitis B: A preliminary finding-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of HBeAg loss after nucleos(t)ide analogues treatment for chronic hepatitis B: A preliminary finding

Published:2020-06 Issue:1 Volume:8 Page:10-18
ISSN:2351-9797
Container-title:Advances in Digestive Medicine
language:en
Short-container-title:Adv in Digestive Med

Author:

Wen Shi‐Chi¹,Tsai Chi‐Chang²,Cheng Lung‐Chih¹,Huang Chien‐Wei²,Kuo Wu‐Hsien³⁴^ORCID

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine Pao‐Chien Hospital Pingtung Taiwan

2. Division of Gastroenterology, Department of Internal Medicine Kaohsiung Armed Forces General Hospital Kaohsiung Taiwan

3. Division of Gastroenterology, Department of Internal Medicine Yuan‐Sheng Hospital Changhua Taiwan

4. Division of Gastroenterology, Department of Internal Medicine National Defense Medical Center Taipei Taiwan

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/aid2.13190

Reference32 articles.

1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

2. Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir

3. Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

4. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

5. Current treatment of hepatitis B

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic hepatitis B infection biochemical, virological and tissue treatment response in correlation with platelet-lymphocyte ratio (PLR) and neutrophil-lymphocyte ratio (NLR) in Egyptian patients infected with chronic hepatitis B virus;The Egyptian Journal of Haematology;2023-10

2. Predictors of treatment efficacy with nucleos(t)ide analogues for chronic hepatitis B;Experimental and Clinical Gastroenterology;2023-07-26

3. The unsolved issues in oral antiviral therapy in HBeAg positive chronic hepatitis B patients;Advances in Digestive Medicine;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3